On April 15, one week after Matthew Kacsmaryk suspended approval of the abortion pill mifepristone, the Washington Post published what it framed as a scandalous story about the Texas judge.
When he got word of his impending nomination in April 2017, the Post claimed, Kacsmaryk, then the deputy general counsel of the religious freedom group First Liberty Institute, removed his name from an article he had allegedly drafted for the Texas Review of Law and…